Ftse Mib
35.952,39
-0,53%
DAX
20.972,46
-0,15%
S&P 500
5.996,66
1,00%
NASDAQ
19.630,20
1,51%
Bitcoin
104.356,05
2,27%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Gilead Sciences Inc (GILD) Gilead Sciences Inc (GILD) Notizie

Gilead Sciences Inc

GILD
91,84
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 13:15:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
16/1/202521:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/1/202522:18EDGAR2Form 144 - Report of proposed sale of securities
11/1/202517:00BWGilead and LEO Pharma Enter Into Strategic Partnership to..
10/1/202521:46EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
04/1/202500:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202500:33EDGAR2Form 3 - Initial statement of beneficial ownership of..
24/12/202402:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/12/202402:17EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
20/12/202422:05BWGilead Sciences to Present at Upcoming Investor Conference
19/12/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202422:15EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
17/12/202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202414:30BWU.S. FDA Grants Breakthrough Therapy Designation to..
17/12/202413:00BWGilead and Terray Therapeutics Announce Multi-Target..
16/12/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202422:08EDGAR2Form 144 - Report of proposed sale of securities
13/12/202412:37BWGilead’s Seladelpar Receives Positive CHMP Opinion for..
12/12/202423:30BWGilead Sciences Appoints Dietmar Berger, MD, PhD, as Chief..
12/12/202401:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202401:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202401:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202401:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202401:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202423:45BWKite’s Yescarta® Only CAR T-Cell Therapy to Show Durable..
09/12/202422:30BWLongest Follow-Up Data Reported for Kite’s Tecartus® CAR..
08/12/202418:30BWKite Presents New Data Underscoring Curative Potential of..
03/12/202420:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/12/202413:00BWGilead and Tubulis Enter Into Exclusive Option and License..
30/11/202402:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202420:35EDGAR2Form 144 - Report of proposed sale of securities
28/11/202400:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202423:00BWGilead Announces New England Journal of Medicine Publication..
27/11/202422:15EDGAR2Form 144 - Report of proposed sale of securities
27/11/202401:31EDGAR2Form 144 - Report of proposed sale of securities
20/11/202422:15EDGAR2Form 8-K - Current report
15/11/202422:12EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/11/202417:00BWGilead’s Livdelzi (Seladelpar) Demonstrated a Sustained..
14/11/202402:24BWGilead Prices $3.5 Billion of Senior Unsecured Notes
13/11/202423:13EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
13/11/202415:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13/11/202412:45BWGilead Presents Full PURPOSE 2 Data Results for Twice-Yearly..
12/11/202414:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202411:30BWScientific Leadership Spotlighted as Gilead Presents..
08/11/202422:05BWGilead Sciences to Present at Upcoming Investor Engagements
07/11/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202414:30BWLate-Breaking Clinical Data and Real-World Evidence..
07/11/202412:16IHMARKETNEWSQualcomm Exceeds Expectations, Rises 8%; Wolfspeed Drops 25%..
06/11/202422:19EDGAR2Form 144 - Report of proposed sale of securities
Apertura: Min: Max:
Chiusura: 91,84

La tua Cronologia

NASDAQ
GILD
Gilead Sciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network